| 1 |
27476935 | Novel Antitumor Invasive Actions of p-Cymene by Decreasing MMP-9/TIMP-1 Expression Ratio in Human Fibrosarcoma HT-1080 Cells. | 2016 |
1 |
| 2 |
23268563 | Enhancements of skin cell proliferations and migrations via 6-dehydrogingerdione. | 2013 Feb 13 |
4 |
| 3 |
22974092 | Evaluation of predictive markers for patients with advanced colorectal cancer. | 2012 Sep |
1 |
| 4 |
21354279 | Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKCĪ±/ERK1/2-dependent matrix metalloproteinase-9 expression. | 2011 May 30 |
1 |
| 5 |
21925496 | Cilostazol inhibits matrix invasion and modulates the gene expressions of MMP-9 and TIMP-1 in PMA-differentiated THP-1 cells. | 2011 Nov 30 |
3 |
| 6 |
20471972 | Inhibitory effects of baicalin on IL-1beta- induced MMP-1/TIMP-1 and its stimulated effect on collagen-I production in human periodontal ligament cells. | 2010 Sep 1 |
1 |
| 7 |
19420016 | Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. | 2009 Jul |
1 |
| 8 |
15252145 | Activation of protein kinase C betaII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin. | 2004 Jul |
1 |
| 9 |
15274349 | Role of protein kinase C-dependent signaling pathways in the antiangiogenic properties of nafoxidine. | 2004 May-Jun |
1 |
| 10 |
15324351 | Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 production in human gingival fibroblasts: the role of protein kinase C. | 2004 Oct |
1 |
| 11 |
12620479 | Regulation of matrix metalloproteinase-9 (MMP-9), tissue inhibitor of MMP, and progesterone secretion in luteinized granulosa cells from normally ovulating women with polycystic ovary disease. | 2003 Mar |
1 |
| 12 |
12882798 | Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells. | 2003 Aug |
1 |
| 13 |
12058964 | Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells. | 2002 Apr |
1 |
| 14 |
12134900 | Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase. | 2002 Jul |
1 |
| 15 |
12454040 | Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells. | 2002 Dec |
1 |
| 16 |
10936484 | Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes. | 2000 Aug 11 |
2 |
| 17 |
10329260 | Preeclamptic decidual microvascular endothelial cells express lower levels of matrix metalloproteinase-1 than normals. | 1999 May |
1 |
| 18 |
10487706 | Similar and divergent patterns in the regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of MMP-1 gene expression in benign and malignant human thyroid cells. | 1999 Sep |
3 |
| 19 |
9543636 | Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. | 1998 Mar |
1 |
| 20 |
9548562 | Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C. | 1998 May 1 |
2 |
| 21 |
9568638 | Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells. | 1998 Apr |
2 |
| 22 |
9665201 | Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: specific involvement of TNF receptor type 1. | 1998 Jul |
2 |
| 23 |
9054554 | Distinct mechanisms regulate TIMP-1 expression at different stages of phorbol ester-mediated differentiation of U937 cells. | 1997 Mar 4 |
2 |
| 24 |
9242444 | Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells. | 1997 Aug 1 |
2 |
| 25 |
8613475 | Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells. | 1996 May |
2 |
| 26 |
8706790 | Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. | 1996 Jan-Apr |
1 |
| 27 |
8878412 | Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression. | 1996 Sep |
2 |
| 28 |
8913498 | Translational augmentation of pro-matrix metalloproteinase 3 (prostromelysin 1) and a tissue inhibitor of metalloproteinases (TIMP)-1 mRNAs by epidermal growth factor and transforming growth factor alpha, but not by interleukin 1 alpha or 12-O-tetradecanoylphorbol 13-acetate in human uterine cervical fibroblasts: the possible involvement of an atypical protein kinase C. | 1996 Oct |
4 |
| 29 |
7543547 | Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. | 1995 Aug |
1 |
| 30 |
7615646 | Interleukin-1 beta induction of tissue inhibitor of metalloproteinase (TIMP-1) is functionally antagonized by prostaglandin E2 in human synovial fibroblasts. | 1995 Apr |
1 |
| 31 |
7616276 | Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. | 1995 Aug |
2 |
| 32 |
7512058 | Interstitial collagenase is required for angiogenesis in vitro. | 1994 Apr |
1 |
| 33 |
8253535 | TPA-enhanced invasion of Matrigel associated with augmentation of cell motility but not metalloproteinase activity in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1. | 1993 Dec 2 |
2 |
| 34 |
8253876 | Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B). | 1993 Dec |
1 |
| 35 |
8268245 | Involvement of protein kinase C in the interleukin 1 alpha-induced gene expression of matrix metalloproteinases and tissue inhibitor-1 of metalloproteinases (TIMP-1) in human uterine cervical fibroblasts. | 1993 Dec 16 |
2 |
| 36 |
8476858 | Molecular mechanisms regulating the production of collagenase and TIMP in U937 cells: evidence for involvement of delayed transcriptional activation and enhanced mRNA stability. | 1993 Apr 27 |
6 |
| 37 |
1284126 | Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. | 1992 |
2 |
| 38 |
1330702 | Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2). Up-regulation by interleukin-6 and transforming growth factor beta 1. | 1992 Nov 23 |
1 |
| 39 |
2159816 | Increased erythroid potentiating activity/tissue inhibitor of metalloproteinases and jun/fos transcription factor complex characterize tumor promoter-induced megakaryoblastic differentiation of K562 leukemia cells. | 1990 May 15 |
9 |
| 40 |
2174435 | Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. | 1990 Dec 5 |
1 |
| 41 |
2176183 | Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium. | 1990 Dec |
2 |
| 42 |
2982848 | Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. | 1985 Mar 10 |
1 |
| 43 |
2991920 | Differentiation of a human leukemia cell line and expression of collagenase inhibitor. | 1985 Aug |
1 |
| 44 |
2992392 | Coregulation of collagenase and collagenase inhibitor production by phorbol myristate acetate in human skin fibroblasts. | 1985 Aug 15 |
4 |
| 45 |
3894382 | Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. | 1985 Feb |
1 |